Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
Frédéric ToussaintM ErdmannE GroschS SchliepG SchulerReinhard DummerL HeinzerlingPublished in: The British journal of dermatology (2020)